Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Johnson & Johnson Bullish
Description
Johnson & Johnson ($JNJ@US) raised its annual adjusted profit forecast on Tuesday. The firm kept its vaccine sales target of $2.5 billion, but it raised its adjusted earnings per share to between $9.77 and $9.82, outpacing previous estimates by more than 10 cents. The company, however, is facing stiff competition from Moderna ($MRNA@US) and Pfizer ($PFE@US) over COVID-19 vaccines. In Baltimore, a Johnson & Johnson vaccine plant has experienced quality issues, making it difficult to improve vaccine sales in 2022. Johnson & Johnson stock fell nearly three-quarters of a percent in early trading.
More from User
01:07
Gap Slashes Guidance
Benzinga
01:06
Musk Muddles SpaceX IPO
Benzinga
01:07
Waymo Hails Uber
Benzinga
01:11
Ripple CEO Praises Crypto Wins
Benzinga
01:00
BP Board Complaints
Benzinga
01:01
Tesla Leads BEV Market
Benzinga
Related Videos
01:56
Cisco soars after quarterly revenue tops analysts’ estimates
Mint
00:46
Wells Fargo Beats Quarterly Estimates
Benzinga
02:06
Tesla quarterly profit jumps, but revenues miss estimates
s11233
03:41
Temu-owner misses quarterly revenue estimates
CGTN Europe
00:46
Coca-Cola Beats Estimates with Strong Quarterly Earnings and Revenue
Benzinga
00:57
Biotech, Pharma and International Payment Platforms Make End-of-the-Week Gains - Bullish Rippers
Bullish Studio